共 224 条
[1]
Narod S(2016)Can advanced-stage ovarian cancer be cured? Nat rev Clin Oncol 13 255-261
[2]
Bookman MA(2016)Optimal primary therapy of ovarian cancer Ann Oncol 27 i58-i62
[3]
Bergamini A(2017)Cisplatin can be safely administered to ovarian cancer patients with hypersensitivity to carboplatin Gynecol Oncol 144 72-76
[4]
Pisano C(2014)"Platinum resistant" ovarian cancer: what is it, who to treat and how to measure benefit? Gynecol Oncol 133 624-631
[5]
Di Napoli M(2010)Cell signaling by receptor tyrosine kinases Cell 141 1117-1134
[6]
Arenare L(2016)Discoidin domain receptors: potential actors and targets in cancer Front Pharmacol 7 55-321
[7]
Della Pepa C(2012)Discoidin domain receptor tyrosine kinases: new players in cancer progression Cancer Metastasis rev 31 295-1301
[8]
Tambaro R(2003)p53 induction and activation of DDR1 kinase counteract p53-mediated apoptosis and influence p53 regulation through a positive feedback loop Embo j 22 1289-4245
[9]
Facchini G(2013)The EBV oncogene LMP1 protects lymphoma cells from cell death through the collagen-mediated activation of DDR1 Blood 122 4237-271
[10]
Gargiulo P(2014)Micro-RNAs and ovarian cancer: the state of art and perspectives of clinical research Gynecol Endocrinol 30 266-5193